Stay updated with breaking news from Repligen Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gulf International Bank UK Ltd bought a new stake in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 10,515 shares of the biotechnology company’s stock, valued at approximately $1,780,000. A number of other hedge funds and other institutional […]
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. bought a new stake in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 16,431 shares of the biotechnology company’s stock, valued at approximately $2,662,000. Other large investors also recently added […]
Repligen Co. (NASDAQ:RGEN – Get Rating) – Stock analysts at William Blair reduced their Q3 2023 earnings estimates for Repligen in a research report issued on Wednesday, May 3rd. William Blair analyst M. Larew now forecasts that the biotechnology company will post earnings of $0.52 per share for the quarter, down from their prior forecast […]
Geneva Capital Management LLC reduced its position in Repligen Co. (NASDAQ:RGEN – Get Rating) by 8.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 129,065 shares of the biotechnology company’s stock after selling 12,348 shares during the quarter. Geneva […]
Repligen Co. (NASDAQ:RGEN – Get Rating) – Stock analysts at William Blair lifted their Q1 2023 earnings per share estimates for Repligen in a research note issued to investors on Wednesday, April 12th. William Blair analyst M. Larew now expects that the biotechnology company will earn $0.72 per share for the quarter, up from their […]